Leaflet AIRONYL 1.5mg / 5ml syrup


Indicated for: asthma; chronic obstructive pulmonary disease

Route of administration: oral

Substance: terbutaline (beta-2 adrenergic agonist)

ATC: R03CC03 (Respiratory system | Adrenergics for systemic use | Selective beta-2-adrenoreceptor agonists)

Terbutaline is a beta-2 adrenergic agonist used for the treatment of bronchial asthma, chronic obstructive bronchitis, and other respiratory conditions involving bronchospasm. It works by relaxing the smooth muscles of the airways, making breathing easier.

The medication is available in the form of tablets, inhalation solutions, or injections and should be used as directed by a doctor. The dosage and frequency of administration are adjusted based on the severity of symptoms.

Patients should be aware of potential side effects, such as tremors, palpitations, or headaches. It is important to inform the doctor of any unusual symptoms or the use of other medications.

Common side effects include tremors, palpitations, nervousness, and headaches. In rare cases, severe reactions such as cardiac arrhythmias or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about AIRONYL 1.5mg / 5ml

  • Substance: terbutaline
  • Date of last drug list: 01-07-2013
  • Commercial code: W51654001
  • Concentration: 1.5mg / 5ml
  • Pharmaceutical form: syrup
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for terbutaline

Concentrations available for terbutaline

  • 0.5mg/ml
  • 1.5mg/5ml